Denali Therapeutics Inc. DNLI Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Based on trailing twelve months.
The official record: Denali Therapeutics Inc.’s 10-Q, filed August 11, 2025, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s operating margin?
- Denali Therapeutics Inc. (DNLI) reported operating margin of -37,938% in Q2 2024.
- How has Denali Therapeutics Inc.'s operating margin changed year-over-year?
- Denali Therapeutics Inc.'s operating margin decreased by 79678.2% year-over-year, from -47.6% to -37,938%.
- What is the long-term trend for Denali Therapeutics Inc.'s operating margin?
- Over 3 years (2020 to 2023), Denali Therapeutics Inc.'s operating margin has grown at a 47.1% compound annual growth rate (CAGR), from 18.7% to -59.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.